These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29931368)

  • 1. Real-time Endoscopy-Guided Measurement of Rectal Mucosal Admittance Is a Novel and Safe Method for Predicting Ulcerative Colitis Relapse.
    Taida T; Arai M; Fujie M; Akizue N; Ishikawa K; Ohta Y; Hamanaka S; Ishigami H; Okimoto K; Saito K; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Kato N
    Inflamm Bowel Dis; 2018 Oct; 24(11):2360-2365. PubMed ID: 29931368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the usefulness of Capsule Scoring of Ulcerative Colitis in predicting relapse of inactive ulcerative colitis.
    Matsubayashi M; Kobayashi T; Okabayashi S; Nakano M; Sagami S; Ozaki R; Kiyohara H; Morikubo H; Asonuma K; Miyatani Y; Maeda S; Hibi T
    J Gastroenterol Hepatol; 2021 Apr; 36(4):943-950. PubMed ID: 32805065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.
    Theede K; Holck S; Ibsen P; Kallemose T; Nordgaard-Lassen I; Nielsen AM
    Inflamm Bowel Dis; 2016 May; 22(5):1042-8. PubMed ID: 26919460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis.
    Nishio Y; Ando T; Maeda O; Ishiguro K; Watanabe O; Ohmiya N; Niwa Y; Kusugami K; Goto H
    Gut; 2006 Dec; 55(12):1768-73. PubMed ID: 16682428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
    Li Y; Nuij VJ; Baars JE; Biermann K; Kuipers EJ; Peppelenbosch MP; de Haar C; Janneke van der Woude C
    Inflamm Bowel Dis; 2013 Jan; 19(1):132-40. PubMed ID: 22535619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
    Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission.
    Ishida N; Sugiura K; Miyazu T; Tamura S; Suzuki S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Furuta T; Sugimoto K
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00289. PubMed ID: 33512810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and local cytokine production in quiescent ulcerative colitis and its relationship to future relapse: a prospective pilot study.
    Yamamoto T; Umegae S; Kitagawa T; Matsumoto K
    Inflamm Bowel Dis; 2005 Jun; 11(6):589-96. PubMed ID: 15905707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study.
    Langhorst J; Hofstetter A; Wolfe F; Häuser W
    Inflamm Bowel Dis; 2013 Oct; 19(11):2380-6. PubMed ID: 23942564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
    Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
    World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.
    Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Romanko I; Bina V; Malickova K; Kolar M; Lukas M
    Scand J Gastroenterol; 2016; 51(2):196-202. PubMed ID: 26329773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic rectal sparing in children with untreated ulcerative colitis.
    Rajwal SR; Puntis JW; McClean P; Davison SM; Newell SJ; Sugarman I; Stringer MD
    J Pediatr Gastroenterol Nutr; 2004 Jan; 38(1):66-9. PubMed ID: 14676597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study.
    Shimoyama T; Yamamoto T; Umegae S; Matsumoto K
    BMC Gastroenterol; 2018 Aug; 18(1):120. PubMed ID: 30068300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased rectal wall thickness may predict relapse in ulcerative colitis: a pilot follow-up study by ultrasonographic colonoscopy.
    Higaki S; Nohara H; Saitoh Y; Akazawa A; Yanai H; Yoshida T; Okita K
    Endoscopy; 2002 Mar; 34(3):212-9. PubMed ID: 11870572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.